Dec 18 $87.5 / $95 Bull Call Spread
Buy 1x $87.5C · Sell 1x $95C · 31d
Updated Nov 22, 2026 5:27 AM ET · Prev Close $80.04
Cvs Health Corporation (CVS) is trading within a tight intraday band at $80.84 (+1.00%, 0.88x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, CVS is outperforming the S&P 500 by +4.64%. 14-day RSI stands at 36.8, keeping momentum in a bearish regime.
CVS Pharmacy , the retail division of CVS Health NYSE Cvs , and its Well Market store brand consumables line today named Caroline, age 9, of Holmes Beach, Florida, and Zoe, age 12, of Los Angeles, California, the Grand P
Price ($80.84) trades relative to 20-day SMA ($86.94) and 50-day SMA ($88.43).
Compare $8,859 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 29.7% ATM IV.
Buy 1x $87.5C · Sell 1x $95C · 31d
Sell 1x $85P · Buy 1x $80P · 31d
Sell 1x $82.5P · Buy 1x $90/$95C · 31d
CVS Pharmacy , the retail division of CVS Health NYSE Cvs , and its Well Market store brand consumables line today named Caroline, age 9, of Holmes Beach, Florida, and Zoe, age 12, of Los Angeles, California, the Grand P
Aetna For You Baby is a multi-year initiative to achieve a 30-percentage-point increase in access to whole-patient maternal and infant care over the next five years. Today, the Centers for Disease Control and Prevention
One stock in this five-name healthcare basket costs more in annual tax than the other four combined, and the IRS treats its payout differently from the rest. Find out which one belongs in your Roth first.
UnitedHealth shares popped on Friday as TD Cowen analysts raised their rating on the stock to Buy from Hold.
Monitor volume expansion above 1.5x RVOL around $86.94 (20-day SMA resistance) for directional breakout confirmation.
Aetna, a CVS Health company, announced the launch of Aetna For You & Baby, a five-year initiative to connect 90% of Aetna's expecting mothers and their babies to essential, end-to-end care, representing a 30-percentage-point increase.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through …
Receive an email alert when CVS triggers an unusual volume breakout, options sweep, or rating shift.
Cvs Health Corporation (CVS) is trading within a tight intraday band at $80.84 (+1.00%, 0.88x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, CVS is outperforming the S&P 500 by +4.64%. 14-day RSI stands at 36.8, keeping momentum in a bearish regime.
Today's session carries a 64% catalyst conviction score on 0.88x relative volume (moderate participation). Our multi-factor model currently rates CVS as BUY. Review full valuation, quality, and timing signals on the CVS Buy or Sell Decision Brief →
At $80.84, CVS's modeled 1-to-3 session range is $78.29 – $83.39, with a key inflection level at $86.94 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the CVS Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →
RSI at 36.8 reflects soft below-midline momentum. CVS trades at $80.84 relative to its 20-day SMA ($86.94) and 50-day SMA ($88.43), reflecting a bearish moving-average structure.
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.